Exelixis Newsroom

Leerink Partners Maintains Exelixis(EXEL.US) With Hold Rating

Moomoo NewsDec 3 02:32 ET

RBC Capital Sticks to Their Buy Rating for Exelixis (EXEL)

TipRanksNov 27 20:49 ET

A Quick Look at Today's Ratings for Exelixis(EXEL.US), With a Forecast Between $29 to $38

Moomoo NewsOct 31 09:17 ET

Exelixis Price Target Raised to $36.00/Share From $32.00 by Wells Fargo

Dow JonesOct 30 11:11 ET

Exelixis Is Maintained at Outperform by BMO Capital

Dow JonesOct 30 10:07 ET

Exelixis Analyst Ratings

BenzingaOct 30 09:57 ET

A Quick Look at Today's Ratings for Exelixis(EXEL.US), With a Forecast Between $29 to $38

Moomoo NewsOct 30 09:14 ET

Exelixis Analyst Ratings

BenzingaOct 21 13:17 ET

TD Cowen Maintains Exelixis(EXEL.US) With Buy Rating, Raises Target Price to $34

Moomoo NewsOct 21 07:34 ET

Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), Korro Bio (KRRO) and Vertex Pharmaceuticals (VRTX)

TipRanksOct 21 06:58 ET

A Quick Look at Today's Ratings for Exelixis(EXEL.US), With a Forecast Between $30 to $34

Moomoo NewsOct 17 09:06 ET

A Quick Look at Today's Ratings for Exelixis(EXEL.US), With a Forecast Between $27 to $34

Moomoo NewsOct 16 09:04 ET

Exelixis Is Maintained at Market Outperform by JMP Securities

Dow JonesOct 16 07:30 ET

RBC Raises Price Target on Exelixis to $34 From $30, Keeps Outperform Rating

MT NewswiresOct 16 06:27 ET

Goldman Sachs Remains a Sell on Exelixis (EXEL)

TipRanksOct 15 22:55 ET

Exelixis Hold Rating: Navigating Legal Wins and Strategic Acquisitions Amid Uncertain Revenue Transition

TipRanksOct 15 16:27 ET

Exelixis's Legal Triumph and Growth Prospects Bolster Buy Rating

TipRanksOct 15 15:28 ET

Exelixis Analyst Ratings

BenzingaOct 15 13:47 ET

Citi Maintains Exelixis(EXEL.US) With Buy Rating, Maintains Target Price $31

Moomoo NewsOct 15 08:34 ET

Truist Financial Maintains Exelixis(EXEL.US) With Buy Rating, Maintains Target Price $33

Moomoo NewsOct 15 07:32 ET